Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03533517 · ClinicalTrials.gov registry record · NA

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

A NA study of Heart Failure and Cardiomyopathy, Dilated, sponsored by Ancora Heart.

Active
Registry status
NA
Development phase
22
Enrollment target
18
Study locations

NCT03533517 is a NA study of Heart Failure and Cardiomyopathy, Dilated that is active but no longer recruiting, run by Ancora Heart. The registered enrollment target is 22 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The trial reports 18 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03533517, a NA study of Heart Failure and Cardiomyopathy, Dilated, is active but no longer recruiting, sponsored by Ancora Heart.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
22 participants
Enrollment target
18
Study locations

Study Summary

This is a non-randomized, prospective, multi-center Early Feasibility Study to evaluate the AccuCinch® Ventricular Restoration System in Patients with Heart Failure and Reduced Ejection Fraction (HFrEF).

Conditions Studied

Heart Failure Cardiomyopathy, Dilated

Interventions

  • DEVICE AccuCinch® Ventricular Restoration

Study Locations (18)

New York

  • Mt. Sinai - New York
  • Columbia University Medical Center/NYPH - New York
  • Montefiore Medical Center - The Bronx

Pennsylvania

  • Pinnacle Health Cardiovascular Institute - Harrisburg
  • Penn State Health Milton S. Hershey Medical Center - Hershey
  • University of Pennsylvania - Philadelphia

Virginia

  • University of Virginia School of Medicine - Charlottesville
  • Carilion Roanoke Memorial - Roanoke

California

  • University of California, San Francisco - San Francisco

Georgia

  • Emory University Hospital Midtown - Atlanta

Kentucky

  • University of Louisville - Louisville

Louisiana

  • Cardiovascular Institute of the South - Houma

Minnesota

  • Minneapolis Heart Foundation Institute - Minneapolis

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2018-08-23
Est. Completion 2026-02-28
Phase NA

Sponsor

Ancora Heart

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03533517

The ClinicalTrials.gov registry entry for NCT03533517 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The listed sponsor is Ancora Heart, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which AccuCinch® Ventricular Restoration is the first listed.

NCT03533517 reports 18 study locations spanning 13 distinct geographic areas - top geographies include New York, Pennsylvania, Virginia.

Frequently Asked Questions

What is clinical trial NCT03533517 about?

NCT03533517 is a clinical study titled "Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction". This is a non-randomized, prospective, multi-center Early Feasibility Study to evaluate the AccuCinch® Ventricular Restoration System in Patients with Heart Failure and Reduced Ejection Fraction (HFrEF).

What is the current status of trial NCT03533517?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 22 participants. The study started on 2018-08-23. Estimated completion is 2026-02-28.

What conditions does trial NCT03533517 study?

This clinical trial studies the following conditions: Heart Failure, Cardiomyopathy, Dilated.

What interventions are being tested in trial NCT03533517?

The interventions under investigation include: AccuCinch® Ventricular Restoration (DEVICE).

Who is sponsoring clinical trial NCT03533517?

This trial is sponsored by Ancora Heart, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03533517 being conducted?

This trial has 18 study locations across California, Georgia, Kentucky, Louisiana, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Heart Failure

All registered trials for this condition

Cardiomyopathy, Dilated

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.